Translational Development Acquisition TDACU
NASDAQ TDACU
$11.48 +0.00 (+0.00%)
At close: Nov 5, 2026 · 4:00 PM EST

Translational Development Acquisition (TDACU) EPS (Diluted) (2024 - 2026)

Updated

Translational Development Acquisition's EPS (Diluted) was $0.04 in Q2 2026, down 40.6% from $0.07 a year earlier and down 27.6% from the prior quarter.

Analysis

Translational Development Acquisition (TDACU) EPS (Diluted) (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Translational Development Acquisition's EPS (Diluted) was $0.26 through Jun 30, 2026, up 85.7% year-over-year; for FY2025, it came in at $0.37.

  • In earlier years, EPS (Diluted) was -$0.01 in FY2024 and $5,994 in FY2023.
  • The Q2 2026 figure marks the lowest quarterly EPS (Diluted) since Q4 2024.
  • Per Business Quant data, TDACU's EPS (Diluted) in the three quarters before Q2 2026 was $0.06 (Q1 2026), $0.09 (Q4 2025) and $0.08 (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.04
Mar 31, 2026 0.06
Dec 31, 2025 0.09
Sep 30, 2025 0.08
Jun 30, 2025 0.07
Mar 31, 2025 0.07
Dec 31, 2024 0.00
Sep 30, 2024 -0.02
Jun 30, 2024 0.00
API Access

Translational Development Acquisition EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=TDACU&period=max&api_key=YOUR_API_KEY